Skip to main content
SpringerLink
Log in

Critical care management of acute liver failure

  • Narrative review
  • Published:
Indian Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

The management of acute liver failure (ALF) in modern hepatology intensive care units (ICU) has improved patient outcomes. Critical care management of hepatic encephalopathy, cerebral edema, fluid and electrolytes; prevention of infections and organ support are central to improved outcomes of ALF. In particular, the pathogenesis of encephalopathy is multifactorial, with ammonia, elevated intra-cranial pressure and systemic inflammation playing a central role. Although ALF remains associated with high mortality, the availability of supportive care, including organ failure support such as plasma exchange, timely mechanical ventilation or continuous renal replacement therapy, either conservatively manages patients with ALF or offers bridging therapy until liver transplantation. Thus, appropriate critical care management has improved the likelihood of patient recovery in ALF. ICU care interventions such as monitoring of cerebral edema, fluid status assessment and interventions for sepsis prevention, nutritional support and management of electrolytes can salvage a substantial proportion of patients. In this review, we discuss the key aspects of critical care management of ALF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The manuscript-related data is available from both authors.

References

  1. European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu;, Clinical practice guidelines panel, Wendon J, Panel members, Cordoba J, Dhawan A, et al. EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. J Hepatol. 2017;66:1047–81.

  2. Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of the Liver Consensus Statement on Acute Liver Failure (Part 1): epidemiology, pathogenesis, presentation and prognosis. J Clin Exp Hepatol. 2020;10:339–76.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Polson J, Lee WM. American Association for the Study of Liver Disease. AASLD position paper: the management of acute liver failure. Hepatology. 2005;41:1179–97.

  4. Stravitz RT, Lisman T, Luketic VA, et al. Minimal effects of acute liver injury/acute liver failure on hemostasis as assessed by thromboelastography. J Hepatol. 2012;56:129–36.

    Article  PubMed  Google Scholar 

  5. Tandon BN, Bernauau J, O’Grady J, et al. Recommendations of the International Association for the Study of the Liver Subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4.

    Article  CAS  PubMed  Google Scholar 

  6. Tujios SR, Lee WM. Acute liver failure induced by idiosyncratic reaction to drugs: challenges in diagnosis and therapy. Liver Int. 2018;38:6–14.

    Article  PubMed  Google Scholar 

  7. Choudhary NS, Saigal S, Saraf N, et al. Good outcome of living donor liver transplantation in drug-induced acute liver failure: a single-center experience. Clin Transplant. 2017;31. https://doi.org/10.1111/ctr.12907.

  8. Lee WM. Etiologies of acute liver failure. Semin Liver Dis. 2008;28:142–52.

    Article  PubMed  Google Scholar 

  9. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet. 2010;376:190–201.

    Article  PubMed  Google Scholar 

  10. Rao A, Rule JA, Cerro-Chiang G, et al. Role of hepatitis c infection in acute liver injury/acute liver failure in North America. Dig Dis Sci. 2023;68:304–11.

    Article  CAS  PubMed  Google Scholar 

  11. Pan C, Gish R, Jacobson IM, Hu KQ, Wedemeyer H, Martin P. Diagnosis and management of hepatitis delta virus infection. Dig Dis Sci. 2023;68:3237–48.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Gupta E, Ballani N, Kumar M, Sarin SK. Role of non-hepatotropic viruses in acute sporadic viral hepatitis and acute-on-chronic liver failure in adults. Indian J Gastroenterol. 2015;34:448–52.

    Article  PubMed  Google Scholar 

  13. Rabaan AA, Bakhrebah MA, Nassar MS, et al. Suspected adenovirus causing an emerging HEPATITIS among children below 10 years: a review. Pathogens. 2022;11:712.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mellinger JL, Rossaro L, Naugler WE, et al. Epstein-Barr virus (EBV) related acute liver failure: a case series from the US Acute Liver Failure Study Group. Dig Dis Sci. 2014;59:1630–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Archer JS. Acute liver failure in pregnancy. A case report. J Reprod Med. 2001;46:137–40.

    CAS  PubMed  Google Scholar 

  16. Wang LC, Tsai HP, Chen SH, Wang SM. Therapeutics for fulminant hepatitis caused by enteroviruses in neonates. Front Pharmacol. 2022;13:1014823.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Song ATW, Carneiro D’Albuquerque LA. Acute liver failure secondary to yellow fever: a challenging scenario. Clin Liver Dis (Hoboken). 2019;13:58–61.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Leowattana W, Leowattana T. Dengue hemorrhagic fever and the liver. World J Hepatol. 2021;13:1968–76.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Gupta P, Suryadevara M, Das A. Cytomegalovirus-induced hepatitis in an immunocompetent patient. Am J Case Rep. 2014;15:447–9.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lee WM, Squires RH Jr, Nyberg SL, Doo E, Hoofnagle JH. Acute liver failure: summary of a workshop. Hepatology. 2008;47:1401–15.

    Article  PubMed  Google Scholar 

  21. Acharya SK. Acute liver failure: Indian perspective. Clin Liver Dis (Hoboken). 2021;18:143–9.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Karvellas CJ, Stravitz RT. Acute liver failure. In: Arun J. Sanyal TDB, Norah A, Terrault, Keith D, Lindor, editors. Zakim and Boyer’s Hepatology: A Textbook of Liver Disease. 7th ed. Philadelphia, PA: Elsevier; 2018. p. 19103–2899.

  23. Eapen CE, Venkataraman J. Rodenticide (yellow phosphorus poison)-induced hepatotoxicity in India: constraints during management. J Clin Exp Hepatol. 2021;11:414–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Santi L, Maggioli C, Mastroroberto M, Tufoni M, Napoli L, Caraceni P. Acute liver failure caused by Amanita phalloides poisoning. Int J Hepatol. 2012;2012:487480.

  25. Phan T, Desmond C. Hepatitis E infection with acute liver failure. ACG Case Rep J. 2020;7:e00361.

  26. Anand AC, Nandi B, Acharya SK, et al. Indian National Association for the Study of Liver Consensus Statement on Acute Liver Failure (Part-2): management of acute liver failure. J Clin Exp Hepatol. 2020;10:477–517.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Casey LC, Fontana RJ, Aday A, et al. Acute liver failure (ALF) in pregnancy: how much is pregnancy related? Hepatology. 2020;72:1366–77.

  28. De Martin E, Coilly A, Houssel-Debry P, et al. Treatment and prognosis of acute severe autoimmune hepatitis. J Hepatology. 2017;1:S4.

    Article  Google Scholar 

  29. Seetharam A. Intensive care management of acute liver failure: considerations while awaiting liver transplantation. J Clin Translation Hepatol. 2019;7:384.

    Google Scholar 

  30. Castaldo ET, Chari RS. Liver transplantation for acute hepatic failure. HPB (Oxford). 2006;8:29–34.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Montrief T, Koyfman A, Long B. Acute liver failure: a review for emergency physicians. Ame J Emerg Med. 2019;37:329–37.

    Article  Google Scholar 

  32. O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.

    Article  Google Scholar 

  33. Kumar R, Shalimar, Sharma H, et al. Prospective derivation and validation of early dynamic model for predicting outcome in patients with acute liver failure. Gut. 2012;61:1068–75.

  34. Dhiman RK, Jain S, Maheshwari U, et al. Early indicators of prognosis in fulminant hepatic failure: an assessment of the model for end-stage liver disease (MELD) and King’s College Hospital criteria. Liver Transpl. 2007;13:814–21.

    Article  PubMed  Google Scholar 

  35. Craig DG, Ford AC, Hayes PC, Simpson KJ. Systematic review: prognostic tests of paracetamol-induced acute liver failure. Aliment Pharmacol Ther. 2010;31:1064–76.

    Article  CAS  PubMed  Google Scholar 

  36. McPhail MJ, Wendon JA, Bernal W. Meta-analysis of performance of King’s College Hospital Criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492–9.

    Article  PubMed  Google Scholar 

  37. Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatology. 2007;45:789–96.

    Article  CAS  PubMed  Google Scholar 

  38. Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648–51.

    Article  CAS  PubMed  Google Scholar 

  39. Lin CH, Chen CL, Lin TK, Chen NC, Tsai MH, Chuang YC. Levetiracetam in the treatment of epileptic seizures after liver transplantation. Medicine (Baltimore). 2015;94:e1350.

  40. Warrillow S, Bellomo R. Intensive Care Management of Severe Acute Liver Failure. Annual Update in Intensive Care and Emergency Medicine 2015;2015:415–30. https://doi.org/10.1007/978-3-319-13761-2_30.

  41. Canalese J, Gimson AE, Davis C, Mellon PJ, Davis M, Williams R. Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure. Gut. 1982;23:625–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  42. Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856-64, 64 e1.

  43. Ede RJ, Gimson AE, Bihari D, Williams R. Controlled hyperventilation in the prevention of cerebral oedema in fulminant hepatic failure. J Hepatol. 1986;2:43–51.

    Article  CAS  PubMed  Google Scholar 

  44. Jalan R, Olde Damink SW, Deutz NE, et al. Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failure. Transplantation. 2003;75:2034–9.

    Article  PubMed  Google Scholar 

  45. Dart RC, Mullins ME, Matoushek T, et al. Management of acetaminophen poisoning in the US and Canada: a consensus statement. JAMA Netw Open. 2023;6:e2327739.

  46. Floersheim GL, Eberhard M, Tschumi P, Duckert F. Effects of penicillin and silymarin on liver enzymes and blood clotting factors in dogs given a boiled preparation of Amanita phalloides. Toxicol Appl Pharmacol. 1978;46:455–62.

  47. Koppel C. Clinical symptomatology and management of mushroom poisoning. Toxicon. 1993;31:1513–40.

    Article  CAS  PubMed  Google Scholar 

  48. Fujiwara K, Yasui S, Haga Y, et al. Early combination therapy with corticosteroid and nucleoside analogue induces rapid resolution of inflammation in acute liver failure due to transient hepatitis B virus infection. Intern Med. 2018;57:1543–52.

  49. Goya T, Kurashige T, Kurokawa M, et al. The combination of nucleotide analog therapy and steroid pulse therapy for acute HBV infection effectively promotes HBV clearance. Gastroenterology Insights. 2021;13:1–8.

    Article  Google Scholar 

  50. Ichai P, Roque Afonso AM, Sebagh M, et al. Herpes simplex virus-associated acute liver failure: a difficult diagnosis with a poor prognosis. Liver Transpl. 2005;11:1550–5.

    Article  PubMed  Google Scholar 

  51. Karkhanis J, Verna EC, Chang MS, et al. Steroid use in acute liver failure. Hepatology. 2014;59:612–21.

    Article  CAS  PubMed  Google Scholar 

  52. Sen S, Felldin M, Steiner C, et al. Albumin dialysis and molecular adsorbents recirculating system (MARS) for acute Wilson’s disease. Liver Transpl. 2002;8:962–7.

    Article  PubMed  Google Scholar 

  53. Pham HP, Schwartz J, Cooling L, et al. Report of the ASFA apheresis registry study on Wilson’s disease. J Clin Apher. 2016;31:11–5.

    Article  PubMed  Google Scholar 

  54. Abolfazl Avan HRK, Tjaard U Hoogenraad. Initial zinc therapy in Wilson’s disease with acute liver failure and copper intoxication: a clinical observation. Abstracts of the Seventeenth International Congress of Parkinson’s Disease and Movement Disorders: Movement Disorder; 2–13.

  55. Hariharan D, Das MK, Shepard DS, Arora NK. Economic burden of dengue illness in India from 2013 to 2016: a systematic analysis. Int J Infect Dis. 2019;84S:S68–73.

    Article  PubMed  Google Scholar 

  56. Jain K, Gupta P, Balodhi A, Deeba F, Salam N. Prevalence of pregnancy associated malaria in India. Front Glob Womens Health. 2022;3:832880.

    Article  PubMed  PubMed Central  Google Scholar 

  57. John J, Van Aart CJ, Grassly NC. The burden of typhoid and paratyphoid in India: systematic review and meta-analysis. PLoS Negl Trop Dis. 2016;10:e0004616.

  58. Moola S, Beri D, Salam A, Jagnoor J, Teja A, Bhaumik S. Leptospirosis prevalence and risk factors in India: evidence gap maps. Trop Doct. 2021;51:415–21.

    Article  PubMed  Google Scholar 

  59. Anand AC, Garg HK. Approach to clinical syndrome of jaundice and encephalopathy in tropics. J Clin Exp Hepatol. 2015;5 Suppl 1:S116–30.

  60. Reynolds AS, Brush B, Schiano TD, Reilly KJ, Dangayach NS. Neurological monitoring in acute liver failure. Hepatology. 2019;70:1830–5.

    Article  PubMed  Google Scholar 

  61. Chen JW, Gombart ZJ, Rogers S, Gardiner SK, Cecil S, Bullock RM. Pupillary reactivity as an early indicator of increased intracranial pressure: the introduction of the Neurological Pupil index. Surg Neurol Int. 2011;2:82.

  62. Vijay P, Lal BB, Sood V, Khanna R, Patidar Y, Alam S. Dynamic Optic Nerve Sheath Diameter (ONSD) guided management of raised intracranial pressure in pediatric acute liver failure. Hepatol Int. 2021;15:502–9.

    Article  PubMed  Google Scholar 

  63. Bhardwaj A, Bhagat H, Grover VK. Jugular venous oximetry. J Neuroanaesthesiol Critical Care. 2015;2:225–31.

    Article  Google Scholar 

  64. Paschoal FM Jr, Nogueira RC, Ronconi Kde A, de Lima OM, Teixeira MJ, Bor-Seng-Shu E. Multimodal brain monitoring in fulminant hepatic failure. World J Hepatol. 2016;8:915–23.

  65. Hwang S, Lee SG, Park JI, et al. Continuous peritransplant assessment of consciousness using bispectral index monitoring for patients with fulminant hepatic failure undergoing urgent liver transplantation. Clin Transplant. 2010;24:91–7.

    Article  PubMed  Google Scholar 

  66. Abdo-Cuza AA. Acute Liver Failure (ALF) in ICU: Usefulness of Transcranial Doppler (TCD/TCCS). In: Rodríguez CN, et al., editors. Neurosonology in Critical Care. Springer. 2022;817–27. https://doi.org/10.1007/978-3-030-81419-9_50.

  67. Rajajee V, Williamson CA, Fontana RJ, Courey AJ, Patil PG. Noninvasive intracranial pressure assessment in acute liver failure. Neurocrit Care. 2018;29:280–90.

    Article  PubMed  Google Scholar 

  68. Kawakami M, Koda M, Murawaki Y. Cerebral pulsatility index by transcranial Doppler sonography predicts the prognosis of patients with fulminant hepatic failure. Clin Imaging. 2010;34:327–31.

    Article  PubMed  Google Scholar 

  69. Picard B, Sigaut S, Roux O, et al. Evaluation of transcranial Doppler use in patients with acute liver failure listed for emergency liver transplantation. Clin Transplant. 2023;37:e14975.

  70. Reier L, Fowler JB, Arshad M, et al. Optic disc edema and elevated intracranial pressure (ICP): a comprehensive review of papilledema. Cureus. 2022;14:e24915.

  71. Richards E, Munakomi S, Mathew D. Optic Nerve Sheath Ultrasound. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.

  72. Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure–a controlled clinical trial. J Hepatol. 2004;41:89–96.

    Article  CAS  PubMed  Google Scholar 

  73. Benedetti GM, Guerriero RM, Press CA. Review of noninvasive neuromonitoring modalities in children II: EEG, qEEG. Neurocrit Care. 2023;39:618–38.

    Article  PubMed  Google Scholar 

  74. Deep A, Alexander EC, Bulut Y, et al. Advances in medical management of acute liver failure in children: promoting native liver survival. Lancet Child Adolesc Health. 2022;6:725–37.

    Article  PubMed  Google Scholar 

  75. Newey CR, Sarwal A, Hantus S. Continuous electroencephalography (cEEG) changes precede clinical changes in a case of progressive cerebral edema. Neurocrit Care. 2013;18:261–5.

    Article  CAS  PubMed  Google Scholar 

  76. Hussain E, Grimason M, Goldstein J, et al. EEG abnormalities are associated with increased risk of transplant or poor outcome in children with acute liver failure. J Pediatr Gastroenterol Nutr. 2014;58:449–56.

    Article  PubMed  Google Scholar 

  77. Ranjan P, Mishra AM, Kale R, Saraswat VA, Gupta RK. Cytotoxic edema is responsible for raised intracranial pressure in fulminant hepatic failure: in vivo demonstration using diffusion-weighted MRI in human subjects. Metab Brain Dis. 2005;20:181–92.

    Article  PubMed  Google Scholar 

  78. Chavarria L, Alonso J, Rovira A, Cordoba J. Neuroimaging in acute liver failure. Neurochem Int. 2011;59:1175–80.

    Article  CAS  PubMed  Google Scholar 

  79. Jadaun SS, Sharma S, Madhusudhan KS, et al. Spectrum of neuroimaging abnormalities in brain in patients of acute-on-chronic liver failure. J Clin Exp Hepatol. 2022;12:343–52.

    Article  CAS  PubMed  Google Scholar 

  80. Barber PA, Hill MD, Eliasziw M, et al. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry. 2005;76:1528–33.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Vilela P, Rowley HA. Brain ischemia: CT and MRI techniques in acute ischemic stroke. Eur J Radio. 2017;96:162–72.

    Article  Google Scholar 

  82. Moraes FM, Silva GS. Noninvasive intracranial pressure monitoring methods: a critical review. Arq Neuropsiquiatr. 2021;79:437–46.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Nakao M, Nakayama N, Uchida Y, et al. Nationwide survey for acute liver failure and late-onset hepatic failure in Japan. J Gastroenterol. 2018;53:752–69.

    Article  PubMed  Google Scholar 

  84. Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology. 2007;46:1844–52.

    Article  CAS  PubMed  Google Scholar 

  85. Jayalakshmi VT, Bernal W. Update on the management of acute liver failure. Curr Opin Crit Care. 2020;26:163–70.

    Article  PubMed  Google Scholar 

  86. Mokri B. The Monro-Kellie hypothesis: applications in CSF volume depletion. Neurology. 2001;56:1746–8.

    Article  CAS  PubMed  Google Scholar 

  87. Kalal CR, Maiwall R, Choudhary A, et al. Mannitol is comparable to hypertonic saline for raised intracranial pressure in acute liver failure (MAHAL Study): a randomized controlled trial. Dig Dis. 2022;40:607–15.

    Article  PubMed  Google Scholar 

  88. de Lacerda GCB. Treating seizures in renal and hepatic failure. J Epilepsy Clin Neurophysiol. 2008;14Suppl2:46–50.

  89. Wijdicks EF, Nyberg SL. Propofol to control intracranial pressure in fulminant hepatic failure. Transplant Proc. 2002;34:1220–2.

    Article  CAS  PubMed  Google Scholar 

  90. Ong JP, Aggarwal A, Krieger D, et al. Correlation between ammonia levels and the severity of hepatic encephalopathy. Am J Med. 2003;114:188–93.

    Article  CAS  PubMed  Google Scholar 

  91. Kramer L, Tribl B, Gendo A, et al. Partial pressure of ammonia versus ammonia in hepatic encephalopathy. Hepatology. 2000;31:30–4.

    Article  CAS  PubMed  Google Scholar 

  92. Cardoso FS, Gottfried M, Tujios S, Olson JC, Karvellas CJ, Group USALFS. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure. Hepatology. 2018;67:711–20.

  93. Kumar R, Shalimar, Sharma H, et al. Persistent hyperammonemia is associated with complications and poor outcomes in patients with acute liver failure. Clin Gastroenterol Hepatol. 2012;10:925–31.

  94. Acharya SK, Bhatia V, Sreenivas V, Khanal S, Panda SK. Efficacy of L-ornithine L-aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology. 2009;136:2159–68.

    Article  CAS  PubMed  Google Scholar 

  95. Alba L, Hay J, Angulo P, Lee W. Lactulose therapy in acute liver failure. J Hepatol. 2002;36:33.

    Article  Google Scholar 

  96. Kulkarni AV, Avadhanam M, Karandikar P, et al. Antibiotics with or without Rifaximin for acute hepatic Encephalopathy in critically ill patients with cirrhosis: a double-blind, randomized controlled (ARiE) trial. Am J Gastroenterol. 2024. https://doi.org/10.14309/ajg.0000000000002575.

  97. Als-Nielsen B, Koretz RL, Kjaergard LL, Gluud C. Branched-chain amino acids for hepatic encephalopathy. Cochrane Database Syst Rev. 2003:CD001939.

  98. Abenavoli L, Maurizi V, Boccuto L, et al. Nutritional support in acute liver failure. Diseases. 2022;10:108.

  99. Belanger-Quintana A, Arrieta Blanco F, Barrio-Carreras D, et al. Recommendations for the diagnosis and therapeutic management of hyperammonaemia in paediatric and adult patients. Nutrients. 2022;14:2755.

  100. Stravitz RT, Kramer DJ. Management of acute liver failure. Nat Rev Gastroenterol Hepatol. 2009;6:542–53.

    Article  PubMed  Google Scholar 

  101. Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol. 2016;64:69–78.

    Article  PubMed  Google Scholar 

  102. Premkumar M, Kajal K, Kulkarni AV, Gupta A, Divyaveer S. Point-of-care echocardiography and hemodynamic monitoring in cirrhosis and acute-on-chronic liver failure in the COVID-19 era. J Intensive Care Med. 2021;36:511–23.

    Article  PubMed  Google Scholar 

  103. van Limmen J, Iturriagagoitia X, Verougstraete M, et al. Effect of norepinephrine infusion on hepatic blood flow and its interaction with somatostatin: an observational cohort study. BMC Anesthesiol. 2022;22:202.

  104. Eefsen M, Dethloff T, Frederiksen HJ, Hauerberg J, Hansen BA, Larsen FS. Comparison of terlipressin and noradrenalin on cerebral perfusion, intracranial pressure and cerebral extracellular concentrations of lactate and pyruvate in patients with acute liver failure in need of inotropic support. J Hepatol. 2007;47:381–6.

    Article  CAS  PubMed  Google Scholar 

  105. Shawcross DL, Davies NA, Mookerjee RP, et al. Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe encephalopathy. Hepatology. 2004;39:471–5.

    Article  CAS  PubMed  Google Scholar 

  106. Harry R, Auzinger G, Wendon J. The effects of supraphysiological doses of corticosteroids in hypotensive liver failure. Liver Int. 2003;23:71–7.

    Article  CAS  PubMed  Google Scholar 

  107. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012;120:c179-84.

  108. Leithead JA, Ferguson JW, Bates CM, et al. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut. 2009;58:443–9.

    Article  CAS  PubMed  Google Scholar 

  109. Moore K. Renal failure in acute liver failure. Eur J Gastroenterol Hepatol. 1999;11:967–75.

    Article  CAS  PubMed  Google Scholar 

  110. Tujios SR, Hynan LS, Vazquez MA, et al. Risk factors and outcomes of acute kidney injury in patients with acute liver failure. Clin Gastroenterol Hepatol. 2015;13:352–9.

    Article  PubMed  Google Scholar 

  111. Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. Crit Care Med. 1993;21:328–38.

    Article  CAS  PubMed  Google Scholar 

  112. Kappus MR. Acute hepatic failure and nutrition. Nutr Clin Pract. 2020;35:30–5.

    Article  Google Scholar 

  113. Shah AD, Wood DM, Dargan PI. Understanding lactic acidosis in paracetamol (acetaminophen) poisoning. British J Clin Pharmacol. 2011;71:20–8.

    Article  CAS  Google Scholar 

  114. Shalimar, Acharya SK. Management in acute liver failure. J Clin Exp Hepatol. 2015;5 Suppl 1:S104–15.

  115. Moore JK, Love E, Craig DG, Hayes PC, Simpson KJ. Acute kidney injury in acute liver failure: a review. Expert Rev Gastroenterol Hepatol. 2013;7:701–12.

    Article  CAS  PubMed  Google Scholar 

  116. Kramer AH, Roberts DJ, Zygun DA. Optimal glycemic control in neurocritical care patients: a systematic review and meta-analysis. Crit Care. 2012;16:R203.

  117. Stroud M, Duncan H, Nightingale J. Guidelines for enteral feeding in adult hospital patients. Gut. 2003;52 Suppl 7:vii1-vii12.

  118. Baquerizo A, Anselmo D, Shackleton C, et al. Phosphorus ans an early predictive factor in patients with acute liver failure. Transplantation. 2003;75:2007–14.

    Article  CAS  PubMed  Google Scholar 

  119. Khuroo MS. Acute liver failure in India. Hepatology. 1997;26:244–6.

    Article  CAS  PubMed  Google Scholar 

  120. Antoniades CG, Berry PA, Davies ET, et al. Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure. Hepatology. 2006;44:34–43.

    Article  CAS  PubMed  Google Scholar 

  121. Rolando N, Harvey F, Brahm J, et al. Fungal infection: a common, unrecognised complication of acute liver failure. J Hepatol. 1991;12:1–9.

    Article  CAS  PubMed  Google Scholar 

  122. Acharya SK, Panda SK, Saxena A, Gupta SD. Acute hepatic failure in India: a perspective from the East. J Gastroenterol Hepatol. 2000;15:473–9. https://doi.org/10.1046/j.1440-1746.2000.02073.x.

    Article  CAS  PubMed  Google Scholar 

  123. Kaur P, Verma N, Valsan A, et al. Prevalence, risk factors, and impact of bacterial or fungal infections in acute liver failure patients from India. Dig Dis Sci. 2023;68:4022–38.

    Article  PubMed  Google Scholar 

  124. Karvellas CJ, Cavazos J, Battenhouse H, et al. Effects of antimicrobial prophylaxis and blood stream infections in patients with acute liver failure: a retrospective cohort study. Clin Gastroenterol Hepatol. 2014;12:1942-9. e1.

  125. Vaquero J, Polson J, Chung C, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125:755–64.

    Article  PubMed  Google Scholar 

  126. Church DL, Cerutti L, Gurtler A, Griener T, Zelazny A, Emler S. Performance and application of 16S rRNA gene cycle sequencing for routine identification of bacteria in the clinical microbiology laboratory. Clin Microbiol Rev. 2020;33:e00053-19.

  127. Fernández J, Piano S, Bartoletti M, Wey EQ. Management of bacterial and fungal infections in cirrhosis: the MDRO challenge. J Hepatol. 2021;75 Suppl 1:S101-s17.

  128. Keighley C, Cooley L, Morris AJ, et al. Consensus guidelines for the diagnosis and management of invasive candidiasis in haematology, oncology and intensive care settings, 2021. Intern Med J. 2021;51Suppl 7:89–117.

    Article  PubMed  Google Scholar 

  129. Douglas AP, Smibert OC, Bajel A, et al. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. 2021;51Suppl 7:143–76.

    Article  PubMed  Google Scholar 

  130. Theel ES, Doern CD. β-D-Glucan testing is important for diagnosis of invasive fungal infections. J Clin Microbiol. 2013;51:3478–83.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  131. Hsu AJ, Tamma PD, Zhang SX. Challenges with utilizing the 1,3-beta-d-glucan and galactomannan assays to diagnose invasive mold infections in immunocompromised children. J Clin Microbiol. 2021;59:e0327620.

  132. Ferrarese A, Cattelan A, Cillo U, et al. Invasive fungal infection before and after liver transplantation. World J Gastroenterol. 2020;26:7485–96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  133. Freire MP, Oshiro IC, Pierrotti LC, et al. Carbapenem-resistant Enterobacteriaceae acquired before liver transplantation: impact on recipient outcomes. Transplantation. 2017;101:811–20.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  134. Stravitz RT, Fontana RJ, Meinzer C, et al. Coagulopathy, bleeding events, and outcome according to rotational thromboelastometry in patients with acute liver injury/failure. Hepatology. 2021;74:937–49.

    Article  CAS  PubMed  Google Scholar 

  135. Lisman T, Bakhtiari K, Adelmeijer J, Meijers JC, Porte RJ, Stravitz RT. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost. 2012;10:1312–9.

    Article  CAS  PubMed  Google Scholar 

  136. Smith CB, Hennessey EK, Crossey CD, Crannage AJ. Impact of vitamin K administration on elevated international normalized ratio in chronic liver disease. Clin Appl Thromb Hemost. 2023;29. https://doi.org/10.1177/10760296231164642.

  137. Ozbay Hosnut F, Ozcay F, Selda Bayrakci U, Avci Z, Özbek N. Etiology of hemolysis in two patients with hepatitis A infection: glucose-6-phosphate dehydrogenase deficiency or autoimmune hemolytic anemia. Eur J Pedia. 2008;167:1435–9.

    Article  Google Scholar 

  138. Bhutra A, Giri PP, Ganguly N. Acute hepatic failure with hemolytic anemia due to hepatitis A infection with coexistent glucose-6-phosphate dehydrogenase deficiency. Pediat Infectious Dis. 2015;7:50–2.

    Article  Google Scholar 

  139. Premkumar M, Kulkarni AV, Kajal K, Divyaveer S. Principles, interpretation, and evidence-based role of viscoelastic point-of-care coagulation assays in cirrhosis and liver failure. J Clin Exp Hepatol. 2022;12:533–43.

    Article  CAS  PubMed  Google Scholar 

  140. Larson AM, Polson J, Fontana RJ, et al. Acetaminophen-induced acute liver failure: results of a United States multicenter, prospective study. Hepatology. 2005;42:1364–72.

    Article  CAS  PubMed  Google Scholar 

  141. Maiwall R, Bajpai M, Singh A, et al. Standard-volume plasma exchange improves outcomes in patients with acute liver failure: a randomized controlled trial. Clin Gastroenterol Hepatol. 2022;20:e831–54.

  142. Goel A, Zachariah U, Daniel D, Eapen CE. Growing evidence for survival benefit with plasma exchange to treat liver failure. J Clin Exp Hepatol. 2023;13:1061–73.

    Article  CAS  PubMed  Google Scholar 

  143. Thomas L, Chandran J, Goel A, et al. Improving transplant-free survival with low-volume plasma exchange to treat children with rodenticide induced hepatotoxicity. J Clin Exp Hepatol. 2023;13:252–8.

    Article  CAS  PubMed  Google Scholar 

  144. Larsen FS, Ejlersen E, Hansen BA, Mogensen T, Tygstrup N, Secher NH. Systemic vascular resistance during high-volume plasmapheresis in patients with fulminant hepatic failure: relationship with oxygen consumption. Eur J Gastroenterol Hepatol. 1995;7:887–92.

    CAS  PubMed  Google Scholar 

  145. Govindarajan R, Ramamoorthy G, Shanmugam RM, et al. Rodenticide ingestion is an important cause of acute hepatotoxicity in Tamil Nadu, southern India. Indian J Gastroenterol. 2021;40:373–9.

    Article  PubMed  Google Scholar 

  146. O’Keefe SJ, El-Zayadi AR, Carraher TE, Davis M, Williams R. Malnutrition and immuno-incompetence in patients with liver disease. Lancet. 1980;2 pt 1:615–7.

  147. Plauth M, Bernal W, Dasarathy S, et al. ESPEN guideline on clinical nutrition in liver disease. Clin Nutr. 2019;38:485–521.

    Article  PubMed  PubMed Central  Google Scholar 

  148. Munoz SJ. Nutritional therapies in liver disease. Semin Liver Dis. 1991;11:278–91.

    Article  CAS  PubMed  Google Scholar 

  149. Blot SI, Poelaert J, Kollef M. How to avoid microaspiration? A key element for the prevention of ventilator-associated pneumonia in intubated ICU patients. BMC Infect Dis. 2014;14:119.

  150. Chase RA, Davies M, Trewby PN, Silk DB, Williams R. Plasma amino acid profiles in patients with fulminant hepatic failure treated by repeated polyacrylonitrile membrane hemodialysis. Gastroenterology. 1978;75:1033–40.

    Article  CAS  PubMed  Google Scholar 

  151. Mallick S, Nair K, Thillai M, et al. Liver transplant in acute liver failure - looking back over 10 years. J Clin Exp Hepatol. 2020;10:322–8.

    Article  PubMed  Google Scholar 

  152. Mehrotra S, Mehta N, Rao PS, Lalwani S, Mangla V, Nundy S. Live donor liver transplantation for acute liver failure: a single center experience. Indian J Gastroenterol. 2018;37:25–30.

    Article  PubMed  Google Scholar 

  153. Pamecha V, Vagadiya A, Sinha PK, et al. Living donor liver transplantation for acute liver failure: donor safety and recipient outcome. Liver Transpl. 2019;25:1408–21.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors acknowledge the help of Dr. Jasvinder Nain, in the preparation of this manuscript.

Author information

Authors and Affiliations

  1. Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, 160 012, India

    Surender Singh Sehrawat & Madhumita Premkumar

Authors
  1. Surender Singh Sehrawat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Madhumita Premkumar
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The manuscript was prepared by SSS and review and editing were done by MP. Both authors have approved the final version.

Corresponding author

Correspondence to Madhumita Premkumar.

Ethics declarations

Conflict of interest

SSS and MP declare no competing interests.

Ethical approval and consent to participate

Not applicable

Human ethics

Not applicable

Consent for publication

Not applicable

Disclaimer

The authors are solely responsible for the data and the contents of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or the printer/publishers are responsible for the results/findings and content of this article.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 4100 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sehrawat, S.S., Premkumar, M. Critical care management of acute liver failure. Indian J Gastroenterol (2024). https://doi.org/10.1007/s12664-024-01556-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12664-024-01556-8

Keywords

Search

Navigation